annual CFI:
-$160.20M-$180.40M(-893.07%)Summary
- As of today (June 3, 2025), BIO annual cash flow from investing activities is -$160.20 million, with the most recent change of -$180.40 million (-893.07%) on December 31, 2024.
- During the last 3 years, BIO annual CFI has risen by +$637.18 million (+79.91%).
- BIO annual CFI is now -893.07% below its all-time high of $20.20 million, reached on December 31, 2023.
Performance
BIO Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$2.90M+$33.44M(+109.49%)Summary
- As of today (June 3, 2025), BIO quarterly cash flow from investing activities is $2.90 million, with the most recent change of +$33.44 million (+109.49%) on March 31, 2025.
- Over the past year, BIO quarterly CFI has increased by +$46.00 million (+106.73%).
- BIO quarterly CFI is now -98.35% below its all-time high of $176.04 million, reached on September 30, 2007.
Performance
BIO quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$114.20M+$46.00M(+28.71%)Summary
- As of today (June 3, 2025), BIO TTM cash flow from investing activities is -$114.20 million, with the most recent change of +$46.00 million (+28.71%) on March 31, 2025.
- Over the past year, BIO TTM CFI has dropped by -$161.77 million (-340.05%).
- BIO TTM CFI is now -255.10% below its all-time high of $73.63 million, reached on March 31, 2014.
Performance
BIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BIO Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -893.1% | +106.7% | -340.1% |
| 3 y3 years | +79.9% | +100.3% | +93.1% |
| 5 y5 years | +23.3% | +123.3% | +42.5% |
BIO Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -893.1% | +86.7% | -96.0% | +100.3% | -340.1% | +93.3% |
| 5 y | 5-year | -893.1% | +86.7% | -96.8% | +100.3% | -340.1% | +93.3% |
| alltime | all time | -893.1% | +86.7% | -98.3% | +100.3% | -255.1% | +93.3% |
BIO Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.90M(-109.5%) | -$114.20M(-28.7%) |
| Dec 2024 | -$160.20M(-893.1%) | -$30.54M(-45.1%) | -$160.20M(+178.8%) |
| Sep 2024 | - | -$55.64M(+79.9%) | -$57.47M(+407.2%) |
| Jun 2024 | - | -$30.92M(-28.3%) | -$11.33M(-123.8%) |
| Mar 2024 | - | -$43.10M(-159.7%) | $47.57M(+135.5%) |
| Dec 2023 | $20.20M(-101.7%) | $72.19M(-859.9%) | $20.20M(-118.3%) |
| Sep 2023 | - | -$9.50M(-133.9%) | -$110.55M(-41.7%) |
| Jun 2023 | - | $27.98M(-139.7%) | -$189.47M(-47.7%) |
| Mar 2023 | - | -$70.47M(+20.3%) | -$361.93M(-70.0%) |
| Dec 2022 | -$1.21B(+51.4%) | -$58.56M(-33.8%) | -$1.21B(-29.6%) |
| Sep 2022 | - | -$88.42M(-38.8%) | -$1.72B(+0.4%) |
| Jun 2022 | - | -$144.48M(-84.2%) | -$1.71B(+2.7%) |
| Mar 2022 | - | -$916.14M(+61.5%) | -$1.67B(+108.8%) |
| Dec 2021 | -$797.38M(+1040.8%) | -$567.43M(+597.5%) | -$797.38M(+175.2%) |
| Sep 2021 | - | -$81.35M(-18.9%) | -$289.71M(+146.6%) |
| Jun 2021 | - | -$100.28M(+107.5%) | -$117.50M(+11.1%) |
| Mar 2021 | - | -$48.33M(-19.1%) | -$105.80M(+51.4%) |
| Dec 2020 | -$69.89M(-66.5%) | -$59.75M(-165.8%) | -$69.89M(-2.0%) |
| Sep 2020 | - | $90.85M(-202.6%) | -$71.34M(-73.8%) |
| Jun 2020 | - | -$88.57M(+613.0%) | -$272.10M(+37.0%) |
| Mar 2020 | - | -$12.42M(-79.7%) | -$198.60M(-4.9%) |
| Dec 2019 | -$208.89M(+11.7%) | -$61.20M(-44.3%) | -$208.89M(+3.2%) |
| Sep 2019 | - | -$109.91M(+629.3%) | -$202.50M(+65.8%) |
| Jun 2019 | - | -$15.07M(-33.6%) | -$122.10M(-36.0%) |
| Mar 2019 | - | -$22.71M(-58.6%) | -$190.88M(+2.1%) |
| Dec 2018 | -$186.98M(+6.5%) | -$54.81M(+85.7%) | -$186.98M(+28.7%) |
| Sep 2018 | - | -$29.51M(-64.8%) | -$145.25M(+11.3%) |
| Jun 2018 | - | -$83.84M(+345.6%) | -$130.56M(+55.4%) |
| Mar 2018 | - | -$18.82M(+43.8%) | -$84.00M(-52.2%) |
| Dec 2017 | -$175.57M(-17.9%) | -$13.08M(-11.7%) | -$175.57M(-17.4%) |
| Sep 2017 | - | -$14.81M(-60.3%) | -$212.61M(-15.4%) |
| Jun 2017 | - | -$37.28M(-66.2%) | -$251.23M(-8.1%) |
| Mar 2017 | - | -$110.39M(+120.2%) | -$273.41M(+27.8%) |
| Dec 2016 | -$213.88M(+28.2%) | -$50.12M(-6.2%) | -$213.88M(-13.6%) |
| Sep 2016 | - | -$53.43M(-10.2%) | -$247.53M(+11.8%) |
| Jun 2016 | - | -$59.47M(+16.9%) | -$221.34M(+16.7%) |
| Mar 2016 | - | -$50.86M(-39.3%) | -$189.74M(+13.7%) |
| Dec 2015 | -$166.87M(-12.4%) | -$83.78M(+207.6%) | -$166.87M(+25.9%) |
| Sep 2015 | - | -$27.23M(-2.3%) | -$132.53M(-12.7%) |
| Jun 2015 | - | -$27.86M(-0.5%) | -$151.81M(-17.0%) |
| Mar 2015 | - | -$27.99M(-43.4%) | -$182.93M(-4.0%) |
| Dec 2014 | -$190.51M(<-9900.0%) | -$49.44M(+6.3%) | -$190.51M(+5.5%) |
| Sep 2014 | - | -$46.51M(-21.1%) | -$180.51M(-541.0%) |
| Jun 2014 | - | -$58.99M(+65.8%) | $40.93M(-44.4%) |
| Mar 2014 | - | -$35.57M(-9.8%) | $73.63M(+7912.1%) |
| Dec 2013 | $919.00K(-100.2%) | -$39.45M(-122.5%) | $919.00K(-104.8%) |
| Sep 2013 | - | $174.93M(-765.5%) | -$19.26M(-93.5%) |
| Jun 2013 | - | -$26.28M(-75.7%) | -$298.11M(-29.4%) |
| Mar 2013 | - | -$108.28M(+81.6%) | -$422.38M(+5.5%) |
| Dec 2012 | -$400.39M(+3.6%) | -$59.62M(-42.6%) | -$400.39M(-22.0%) |
| Sep 2012 | - | -$103.93M(-31.0%) | -$513.21M(+10.3%) |
| Jun 2012 | - | -$150.55M(+74.5%) | -$465.09M(+17.6%) |
| Mar 2012 | - | -$86.28M(-50.0%) | -$395.32M(+2.3%) |
| Dec 2011 | -$386.33M(+78.4%) | -$172.44M(+209.0%) | -$386.33M(+45.2%) |
| Sep 2011 | - | -$55.81M(-30.9%) | -$265.99M(-2.0%) |
| Jun 2011 | - | -$80.78M(+4.5%) | -$271.44M(+25.2%) |
| Mar 2011 | - | -$77.29M(+48.3%) | -$216.79M(+0.1%) |
| Dec 2010 | -$216.51M(+23.1%) | -$52.10M(-15.0%) | -$216.51M(+15.8%) |
| Sep 2010 | - | -$61.26M(+134.4%) | -$187.00M(-10.2%) |
| Jun 2010 | - | -$26.14M(-66.1%) | -$208.33M(-13.3%) |
| Mar 2010 | - | -$77.01M(+240.9%) | -$240.25M(+36.5%) |
| Dec 2009 | -$175.95M(+20.4%) | -$22.59M(-72.6%) | -$175.95M(-19.1%) |
| Sep 2009 | - | -$82.59M(+42.3%) | -$217.60M(+32.1%) |
| Jun 2009 | - | -$58.05M(+356.5%) | -$164.72M(+33.0%) |
| Mar 2009 | - | -$12.72M(-80.2%) | -$123.86M(-15.2%) |
| Dec 2008 | -$146.11M(-42.6%) | -$64.24M(+116.2%) | -$146.11M(-69.3%) |
| Sep 2008 | - | -$29.71M(+72.9%) | -$476.36M(+76.0%) |
| Jun 2008 | - | -$17.19M(-50.8%) | -$270.60M(-10.2%) |
| Mar 2008 | - | -$34.96M(-91.1%) | -$301.25M(+18.4%) |
| Dec 2007 | -$254.43M | -$394.49M(-324.1%) | -$254.43M(-483.4%) |
| Sep 2007 | - | $176.04M(-468.0%) | $66.35M(-138.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$47.84M(-503.4%) | -$171.97M(-15.8%) |
| Mar 2007 | - | $11.86M(-116.1%) | -$204.13M(-1.7%) |
| Dec 2006 | -$207.75M(+3266.0%) | -$73.70M(+18.3%) | -$207.75M(+65.0%) |
| Sep 2006 | - | -$62.29M(-22.1%) | -$125.92M(+24.8%) |
| Jun 2006 | - | -$79.99M(-1071.1%) | -$100.92M(+9.9%) |
| Mar 2006 | - | $8.24M(+1.4%) | -$91.82M(+1387.7%) |
| Dec 2005 | -$6.17M(-96.7%) | $8.12M(-121.8%) | -$6.17M(-95.4%) |
| Sep 2005 | - | -$37.29M(-47.4%) | -$135.39M(+14.8%) |
| Jun 2005 | - | -$70.89M(-175.5%) | -$117.89M(+183.3%) |
| Mar 2005 | - | $93.89M(-177.5%) | -$41.61M(-77.7%) |
| Dec 2004 | -$186.32M(-2.1%) | -$121.10M(+512.0%) | -$186.32M(+5.0%) |
| Sep 2004 | - | -$19.79M(-467.3%) | -$177.45M(-9.2%) |
| Jun 2004 | - | $5.39M(-110.6%) | -$195.40M(-11.3%) |
| Mar 2004 | - | -$50.82M(-54.7%) | -$220.34M(+15.8%) |
| Dec 2003 | -$190.24M(+249.3%) | -$112.23M(+197.4%) | -$190.24M(+109.8%) |
| Sep 2003 | - | -$37.73M(+93.0%) | -$90.69M(+37.6%) |
| Jun 2003 | - | -$19.55M(-5.7%) | -$65.93M(-1.0%) |
| Mar 2003 | - | -$20.73M(+63.4%) | -$66.60M(+22.3%) |
| Dec 2002 | -$54.46M(+14.6%) | -$12.68M(-2.3%) | -$54.46M(+2.8%) |
| Sep 2002 | - | -$12.97M(-35.8%) | -$52.99M(-8.6%) |
| Jun 2002 | - | -$20.21M(+135.5%) | -$57.96M(+20.8%) |
| Mar 2002 | - | -$8.58M(-23.5%) | -$47.96M(+0.9%) |
| Dec 2001 | -$47.54M(-611.4%) | -$11.22M(-37.5%) | -$47.54M(+31.6%) |
| Sep 2001 | - | -$17.94M(+75.6%) | -$36.13M(-937.9%) |
| Jun 2001 | - | -$10.22M(+25.2%) | $4.31M(-38.6%) |
| Mar 2001 | - | -$8.16M(-4440.4%) | $7.02M(-24.5%) |
| Dec 2000 | $9.30M(-104.2%) | $188.00K(-99.2%) | $9.30M(-104.6%) |
| Sep 2000 | - | $22.50M(-399.6%) | -$202.09M(-11.2%) |
| Jun 2000 | - | -$7.51M(+27.6%) | -$227.59M(+0.7%) |
| Mar 2000 | - | -$5.88M(-97.2%) | -$225.98M(+1.2%) |
| Dec 1999 | -$223.30M(+782.6%) | -$211.20M(+6940.0%) | -$223.30M(+1081.5%) |
| Sep 1999 | - | -$3.00M(-49.2%) | -$18.90M(+0.5%) |
| Jun 1999 | - | -$5.90M(+84.4%) | -$18.80M(-17.9%) |
| Mar 1999 | - | -$3.20M(-52.9%) | -$22.90M(-9.5%) |
| Dec 1998 | -$25.30M(-54.7%) | -$6.80M(+134.5%) | -$25.30M(-55.2%) |
| Sep 1998 | - | -$2.90M(-71.0%) | -$56.50M(-10.6%) |
| Jun 1998 | - | -$10.00M(+78.6%) | -$63.20M(+10.1%) |
| Mar 1998 | - | -$5.60M(-85.3%) | -$57.40M(+2.7%) |
| Dec 1997 | -$55.90M(+277.7%) | -$38.00M(+295.8%) | -$55.90M(+131.0%) |
| Sep 1997 | - | -$9.60M(+128.6%) | -$24.20M(+33.0%) |
| Jun 1997 | - | -$4.20M(+2.4%) | -$18.20M(+6.4%) |
| Mar 1997 | - | -$4.10M(-34.9%) | -$17.10M(+15.5%) |
| Dec 1996 | -$14.80M(+6.5%) | -$6.30M(+75.0%) | -$14.80M(+23.3%) |
| Sep 1996 | - | -$3.60M(+16.1%) | -$12.00M(+17.6%) |
| Jun 1996 | - | -$3.10M(+72.2%) | -$10.20M(-19.0%) |
| Mar 1996 | - | -$1.80M(-48.6%) | -$12.60M(-9.4%) |
| Dec 1995 | -$13.90M(+6.1%) | -$3.50M(+94.4%) | -$13.90M(-4.1%) |
| Sep 1995 | - | -$1.80M(-67.3%) | -$14.50M(-10.5%) |
| Jun 1995 | - | -$5.50M(+77.4%) | -$16.20M(+14.1%) |
| Mar 1995 | - | -$3.10M(-24.4%) | -$14.20M(+8.4%) |
| Dec 1994 | -$13.10M(+48.9%) | -$4.10M(+17.1%) | -$13.10M(+15.9%) |
| Sep 1994 | - | -$3.50M(0.0%) | -$11.30M(+34.5%) |
| Jun 1994 | - | -$3.50M(+75.0%) | -$8.40M(-28.2%) |
| Mar 1994 | - | -$2.00M(-13.0%) | -$11.70M(+33.0%) |
| Dec 1993 | -$8.80M(-27.3%) | -$2.30M(+283.3%) | -$8.80M(+23.9%) |
| Sep 1993 | - | -$600.00K(-91.2%) | -$7.10M(-19.3%) |
| Jun 1993 | - | -$6.80M(-855.6%) | -$8.80M(-3.3%) |
| Mar 1993 | - | $900.00K(-250.0%) | -$9.10M(-24.8%) |
| Dec 1992 | -$12.10M(-54.5%) | -$600.00K(-73.9%) | -$12.10M(-31.3%) |
| Sep 1992 | - | -$2.30M(-67.6%) | -$17.60M(-26.4%) |
| Jun 1992 | - | -$7.10M(+238.1%) | -$23.90M(+2.1%) |
| Mar 1992 | - | -$2.10M(-65.6%) | -$23.40M(-12.0%) |
| Dec 1991 | -$26.60M(+51.1%) | -$6.10M(-29.1%) | -$26.60M(-2.9%) |
| Sep 1991 | - | -$8.60M(+30.3%) | -$27.40M(+20.2%) |
| Jun 1991 | - | -$6.60M(+24.5%) | -$22.80M(+16.3%) |
| Mar 1991 | - | -$5.30M(-23.2%) | -$19.60M(+11.4%) |
| Dec 1990 | -$17.60M(+4.8%) | -$6.90M(+72.5%) | -$17.60M(+64.5%) |
| Sep 1990 | - | -$4.00M(+17.6%) | -$10.70M(+59.7%) |
| Jun 1990 | - | -$3.40M(+3.0%) | -$6.70M(+103.0%) |
| Mar 1990 | - | -$3.30M | -$3.30M |
| Dec 1989 | -$16.80M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from investing activities?
- What is the all time high annual CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFI year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFI year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFI year-on-year change?
What is Bio-Rad Laboratories annual cash flow from investing activities?
The current annual CFI of BIO is -$160.20M
What is the all time high annual CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from investing activities is $20.20M
What is Bio-Rad Laboratories annual CFI year-on-year change?
Over the past year, BIO annual cash flow from investing activities has changed by -$180.40M (-893.07%)
What is Bio-Rad Laboratories quarterly cash flow from investing activities?
The current quarterly CFI of BIO is $2.90M
What is the all time high quarterly CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from investing activities is $176.04M
What is Bio-Rad Laboratories quarterly CFI year-on-year change?
Over the past year, BIO quarterly cash flow from investing activities has changed by +$46.00M (+106.73%)
What is Bio-Rad Laboratories TTM cash flow from investing activities?
The current TTM CFI of BIO is -$114.20M
What is the all time high TTM CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from investing activities is $73.63M
What is Bio-Rad Laboratories TTM CFI year-on-year change?
Over the past year, BIO TTM cash flow from investing activities has changed by -$161.77M (-340.05%)